TLOG (TetraLogic Pharmaceuticals) Marketable Securities: $0.00 Mil (As of Sep. 2016)


What is TetraLogic Pharmaceuticals Marketable Securities?

TetraLogic Pharmaceuticals TLOG Marketable Securities is $0.00 Mil as of Sep. 2016.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. TetraLogic Pharmaceuticals's Marketable Securities for the quarter that ended in Sep. 2016 was $0.00 Mil.

TetraLogic Pharmaceuticals's annual Marketable Securities increased from Dec. 2013 ($0.00 Mil) to Dec. 2014 ($40.62 Mil) but then declined from Dec. 2014 ($40.62 Mil) to Dec. 2015 ($5.11 Mil).


TetraLogic Pharmaceuticals  (OTCPK:TLOG) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


TetraLogic Pharmaceuticals Marketable Securities Related Terms


TetraLogic Pharmaceuticals Marketable Securities Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Marketable Securities Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Marketable Securities
5.53 0.00 0.00 40.62 5.11

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.63 5.11 0.00 0.00 0.00

TetraLogic Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
TetraLogic Pharmaceuticals (TLOG) has a Marketable Securities of $0.00 Mil as of Sep. 2016. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Marketable Securities too high?
TetraLogic Pharmaceuticals' current Marketable Securities is $0.00 Mil.
How does TetraLogic Pharmaceuticals' Marketable Securities compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Marketable Securities of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Marketable Securities is $0.00 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.